Skip to main content
Samantha Meltzer-Brody, MD, MPH

March 20, 2019

FDA Approves ZULRESSO™ (brexanolone) Injection for Postpartum Depression Following Three Clinical Trials Led by UNC Researcher

ZULRESSO, developed by Sage Therapeutics, is the first and only treatment specifically indicated to treat postpartum depression in women. UNC School of Medicine’s Samantha Meltzer-Brody, MD, MPH, was the principal investigator for three clinical trials showing rapid-reduction in depressive symptoms, and says the approval marks a major step forward in women’s healthcare.

March 7, 2019

New Professional Business Attire Policy, Effective April 1

On April 1, UNC Medical Center will implement a new Professional Business Attire policy. The policy is designed to create standards for professional appearance in order to foster a positive working environment, promote workplace safety, and inspire confidence in quality care service delivery. This policy applies to all personnel performing services for/at UNC Medical Center, including volunteers, research personnel, students, staff, and providers at all levels.